News
From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.
C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias ...
According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...
In a recent regulatory development, the Subject Expert Committee (SEC) under the Oncology division of the Central Drugs ...
A key House committee has blocked a bipartisan amendment to a spending bill that would have given the Department of Defense ...
New research finds that yoga, walking, and other exercises could help you sleep longer and avoid daytime fatigue.
The continuation of enrollment further expands Clearmind’s international clinical network and strengthens the growing interest in CMND-100 as a potentially groundbreaking treatment for AUD.
DelveInsight's " Autosomal Dominant Optic Atrophy Market Insight, Epidemiology And Market Forecast - 2034 " report delivers comprehensive insights into the autosomal dominant optic atrophy treatment ...
12h
GlobalData on MSNViome and Scripps Research to develop precancerous colon polyps’ detection testA collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ...
Vitamins? Minerals? Botanicals? Extracts? Choosing the right supplements can be confusing. An expert offers five tips to help ...
The era of predictive modeling enhanced with machine learning and artificial intelligence (AI) to aid clinical ...
Astria Therapeutics ( NASDAQ: ATXS) is a Boston-based pre-commercial biotech developing two late-stage candidates (Navenibart and STAR-0310). The company was initially known as Catabasis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results